Clinical trial · Interventional
Non-Invasive Diagnosis of Endometrial Cancer
NCT05737797CI-TRIAL-00074243NIECEunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The study aims to determine whether next generation sequencing and microsatellite analysis of cervical cytology is sensitive for the detection of endometrial carcinoma.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| cervical cytology during surgery. | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- Endometrial cancer patients
- description
- Endometrial cancer patients Cervical cytology during surgical intervention.
- interventionNames
- Procedure: cervical cytology during surgery.
Primary outcomes (1)
- measure
- Activating variants and MSI via cytology
- timeFrame
- 16 months
- description
- proportion of cases in whom genetic activating variants and microsatellite instability are detected by cytology
Secondary outcomes (5)
- measure
- Type of variants
- timeFrame
- 16 months
- description
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Endometrial cancer requiring hysterectomy * Patient covered by French social Security * Patient capable of giving written informed consent Exclusion Criteria: \- Chemotherapy
References
Publications (0)
Data not yet available
No reference posted for this study.